|
Name |
Demethylkotanin
|
Molecular Formula | C23H20O8 | |
IUPAC Name* |
8-(4,7-dimethoxy-5-methyl-2-oxochromen-8-yl)-7-hydroxy-4-methoxy-5-methylchromen-2-one
|
|
SMILES |
CC1=CC(=C(C2=C1C(=CC(=O)O2)OC)C3=C(C=C(C4=C3OC(=O)C=C4OC)C)OC)O
|
|
InChI |
InChI=1S/C23H20O8/c1-10-6-12(24)20(22-18(10)14(28-4)8-16(25)30-22)21-13(27-3)7-11(2)19-15(29-5)9-17(26)31-23(19)21/h6-9,24H,1-5H3
|
|
InChIKey |
WNAATGJTLYDMRY-UHFFFAOYSA-N
|
|
Synonyms |
demethylkotanin; desmethylkotanin; CHEBI:64465; 27909-10-0; 8-(4,7-dimethoxy-5-methyl-2-oxochromen-8-yl)-7-hydroxy-4-methoxy-5-methylchromen-2-one; 7-hydroxy-4,4',7'-trimethoxy-5,5'-dimethyl-2H,2'H-8,8'-bichromene-2,2'-dione; CHEMBL518901; DTXSID501132005; Q22984477; (-)-7-Hydroxy-4,4',7'-trimethoxy-5,5'-dimethyl[8,8'-bi-2H-1-benzopyran]-2,2'-dione
|
|
CAS | 27909-10-0 | |
PubChem CID | 44593365 | |
ChEMBL ID | CHEMBL518901 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 424.4 | ALogp: | 3.2 |
HBD: | 1 | HBA: | 8 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 101.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 31 | QED Weighted: | 0.475 |
Caco-2 Permeability: | -4.889 | MDCK Permeability: | 0.00003030 |
Pgp-inhibitor: | 0.2 | Pgp-substrate: | 0.111 |
Human Intestinal Absorption (HIA): | 0.208 | 20% Bioavailability (F20%): | 0.024 |
30% Bioavailability (F30%): | 0.991 |
Blood-Brain-Barrier Penetration (BBB): | 0.009 | Plasma Protein Binding (PPB): | 71.16% |
Volume Distribution (VD): | 0.683 | Fu: | 27.22% |
CYP1A2-inhibitor: | 0.141 | CYP1A2-substrate: | 0.991 |
CYP2C19-inhibitor: | 0.246 | CYP2C19-substrate: | 0.119 |
CYP2C9-inhibitor: | 0.492 | CYP2C9-substrate: | 0.867 |
CYP2D6-inhibitor: | 0.012 | CYP2D6-substrate: | 0.818 |
CYP3A4-inhibitor: | 0.156 | CYP3A4-substrate: | 0.359 |
Clearance (CL): | 11.197 | Half-life (T1/2): | 0.342 |
hERG Blockers: | 0.007 | Human Hepatotoxicity (H-HT): | 0.895 |
Drug-inuced Liver Injury (DILI): | 0.982 | AMES Toxicity: | 0.192 |
Rat Oral Acute Toxicity: | 0.187 | Maximum Recommended Daily Dose: | 0.584 |
Skin Sensitization: | 0.151 | Carcinogencity: | 0.029 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.3 |
Respiratory Toxicity: | 0.268 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000618 | 0.840 | D06GCK | 0.363 | ||||
ENC001765 | 0.835 | D0FA2O | 0.307 | ||||
ENC003879 | 0.551 | D0C1SF | 0.304 | ||||
ENC002002 | 0.446 | D02LZB | 0.290 | ||||
ENC001501 | 0.426 | D09DHY | 0.289 | ||||
ENC001411 | 0.424 | D0D4HN | 0.288 | ||||
ENC002093 | 0.415 | D0Y7TS | 0.280 | ||||
ENC000912 | 0.414 | D0NJ3V | 0.279 | ||||
ENC000922 | 0.414 | D0G4KG | 0.278 | ||||
ENC005172 | 0.408 | D0S9QA | 0.275 |